New study identifies immune markers that may predict cancer development in people living with HIV
The research shows that these immune changes can appear up to a year before a cancer diagnosis, opening new possibilities for early detection.
The research shows that these immune changes can appear up to a year before a cancer diagnosis, opening new possibilities for early detection.
A study by the hospital Clínic Barcelona-IDIBAPS, published in the journal Neurology, confirms the usefulness of a blood-based biomarker to diagnose1
SARS-CoV-2-induced lung injury can produce epithelial and endothelial lung damage half a year after hospital discharge, especially in patient1
The ACROPOLI clinical trial is being launched. It is a pioneering, nationwide research study that aims to assess the efficacy of immunotherapy in 291